MedPath

Kips Bay Medical, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 1
1 (33.3%)

The eMESH 1 Feasibility Study

Phase 1
Conditions
Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)
First Posted Date
2012-08-30
Last Posted Date
2015-02-19
Lead Sponsor
Kips Bay Medical, Inc.
Target Recruit Count
120
Registration Number
NCT01676376
Locations
🇺🇸

Emory University Hospital Midtown, Atlanta, Georgia, United States

🇺🇸

Northeast Georgia Heart Center, Gainesville, Georgia, United States

🇺🇸

Mayo Clinic / St. Mary's Hospital, Rochester, Minnesota, United States

and more 12 locations

The eSVS® Mesh Post-Marketing Trial

Not Applicable
Terminated
Conditions
Myocardial Ischemia
Heart Diseases
Arterial Occlusive Diseases
Coronary Artery Disease
Coronary Disease
Arteriosclerosis
Cardiovascular Diseases
Vascular Diseases
First Posted Date
2012-01-27
Last Posted Date
2016-06-29
Lead Sponsor
Kips Bay Medical, Inc.
Target Recruit Count
8
Registration Number
NCT01520311
Locations
🇨🇭

University Hospital, Basel, Switzerland

The eSVS® Mesh Randomized Post-Market Study

Not Applicable
Terminated
Conditions
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Cardiovascular Diseases
Heart Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
First Posted Date
2011-10-31
Last Posted Date
2014-02-28
Lead Sponsor
Kips Bay Medical, Inc.
Target Recruit Count
12
Registration Number
NCT01462721
Locations
🇩🇪

University Hospital of Kiel, Kiel, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.